1 | 5 ASA, enemas, suppositories, corticosteroids | - | - | - | - | 1件: 97 97 |
2 | ACEI/ARB and corticosteroids | - | - | - | - | 1件: 66 66 |
3 | Azithromycin + N-acetylcystein + inhaled corticosteroid | 1件: Azithromycin Azithromycin | 3件: D02134
D02134
,
D06390
,
D07486
| - | - | 1件: 228 228 |
4 | Behavioral: Duchenne Muscular Dystrophy group without Corticosteroids therapy | - | - | - | - | 1件: 113 113 |
5 | Chronic Corticosteroid Therapy | - | - | - | - | 1件: 113 113 |
6 | Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 85 85 |
7 | Corticosteroid | - | - | - | - | 10件: 13 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 |
8 | Corticosteroid (CS) | - | - | - | - | 1件: 41 41 |
9 | Corticosteroid (prednisolone) | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 85 85 |
10 | Corticosteroid and azathioprine | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 4件: 42 42, 43, 44, 45 |
11 | Corticosteroid and non-biological agents. | - | - | - | - | 1件: 46 46 |
12 | Corticosteroid or NSAID | - | - | - | - | 1件: 46 46 |
13 | Corticosteroid treatment (Methylprednisolone or prednisolone) | 2件: Methylprednisolone Methylprednisolone, Prednisolone | 14件: D00407
D00407
,
D00472
,
D00751
,
D00979
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 64 64 |
14 | Corticosteroids | - | - | - | - | 10件: 41 41, 46, 49, 64, 97, 107, 164, 220, 296, 300 |
15 | Corticosteroids & tanCART19/20 | - | - | - | - | 1件: 13 13 |
16 | Corticosteroids (Aprednislon) | - | - | - | - | 1件: 63 63 |
17 | Corticosteroids (prednisone or prednisolone) | 2件: Prednisolone Prednisolone, Prednisone | 9件: D00472
D00472
,
D00473
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 49 49 |
18 | Corticosteroids for Systemic Use | - | - | - | - | 1件: 41 41 |
19 | Corticosteroids only | - | - | - | - | 1件: 97 97 |
20 | Corticosteroids'therapy | - | - | - | - | 1件: 35 35 |
21 | CS (corticosteroids) Only | - | - | - | - | 1件: 97 97 |
22 | Cumulative corticosteroid exposure | - | - | - | - | 1件: 49 49 |
23 | H02 - Corticosteroidi Sistemici | - | - | - | - | 1件: 299 299 |
24 | Intra-articular corticosteroid injection | - | - | - | - | 1件: 46 46 |
25 | IV Corticosteroid | - | - | - | - | 1件: 97 97 |
26 | Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone | 2件: Mesalazine Mesalazine, Methylprednisolone | 7件: D00377
D00377
,
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
27 | Oral corticosteroids | - | - | - | - | 4件: 13 13, 46, 97, 171 |
28 | Oral corticosteroids (OCS) | - | - | - | - | 1件: 162 162 |
29 | Treatment with topical superpotent corticosteroid therapy | - | - | - | - | 1件: 162 162 |
30 | Valproid acid plus corticosteroids | - | - | - | - | 1件: 26 26 |